Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1.
about
Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma.Beyond the Role of CD55 as a Complement Component.Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer.
P2860
Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@en
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@nl
type
label
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@en
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@nl
prefLabel
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@en
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@nl
P2093
P2860
P356
P1433
P1476
Ten-year follow-up of a prospe ...... n monoclonal antibody PAT-SC1.
@en
P2093
Andreas Rosenwald
Bertram Illert
Burkhard H A von Rahden
Frank Hensel
Stephanie Brändlein
Wolfgang Timmermann
P2860
P304
P356
10.3892/OR.2014.2987
P577
2014-01-20T00:00:00Z